Evidence map›Paper›PMID 33270804›Full record

ArticlePloS one2020

Identification of a new myotropic decapeptide from the skin secretion of the red-eyed leaf frog, Agalychnis callidryas.

Yitian Gao, Renjie Li, Wenqing Yang, Mei Zhou, Lei Wang, Chengbang Ma, Xinping Xi, Tianbao Chen, Chris Shaw, Di Wu

Abstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yitian GaoCollege of Life and Environmental Science, Wenzhou University, Wenzhou, Zhejiang, China.
Renjie LiNatural Drug Discovery Group, School of Pharmacy, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
Wenqing YangCollege of Life and Environmental Science, Wenzhou University, Wenzhou, Zhejiang, China.
Mei ZhouNatural Drug Discovery Group, School of Pharmacy, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
Lei WangNatural Drug Discovery Group, School of Pharmacy, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
Chengbang MaNatural Drug Discovery Group, School of Pharmacy, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
Xinping XiNatural Drug Discovery Group, School of Pharmacy, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
Tianbao ChenNatural Drug Discovery Group, School of Pharmacy, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
Chris ShawNatural Drug Discovery Group, School of Pharmacy, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
Di WuChemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.ORCID 0000-0001-5492-6106

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bradykinin-related peptides (BRPs) family is one of the most significant myotropic peptide families derived from frog skin secretions. Here, a novel BRP callitide was isolated and identified from the red-eyed leaf frog, Agalychnis callidryas, with atypical primary structure FRPAILVRPK-NH2. The mature peptide was cleaved N-terminally at a classic propeptide convertase cleavage site (-KR-) and at the C-terminus an unusual -GKGKGK sequence was removed using the first G residue as an amide donor for the C-terminally-located K residue. Thereafter, the synthetic replicates of callitide were assessed the myotropic activity and showed a significant contraction of balder, with the 0.63 nM EC50 value, more potent than most discovered myotropic peptides. The binding mode was further speculated by molecular docking and stimulation. The result indicated that the C-terminal of callitide might selectively bind to bradykinin receptor B2 (BKRB2). Further investigation of the callitide needs to be done in the future to be exploited as potential future drug leads.

Indexed as

Molecular Docking SimulationReceptor, Bradykinin B2Amphibian ProteinsAnimalsAnuraFemaleMuscle ContractionRatsRats, WistarSkinUrinary BladderAmphibian ProteinsReceptor, Bradykinin B2

Identifiers

PMID33270804
PMCPMC7714090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.